Jason Kolbert
Stock Analyst at D. Boral Capital
(2.15)
# 2,741
Out of 4,732 analysts
222
Total ratings
39.91%
Success rate
-5.71%
Average return
Main Sectors:
Stocks Rated by Jason Kolbert
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARM Carisma Therapeutics | Maintains: Buy | $12 | $0.44 | +2,622.94% | 8 | Jan 17, 2025 | |
| OMER Omeros | Maintains: Buy | $36 | $9.33 | +285.85% | 2 | Jan 16, 2025 | |
| IBRX ImmunityBio | Maintains: Buy | $30 | $2.94 | +920.41% | 7 | Jan 16, 2025 | |
| GOVX GeoVax Labs | Maintains: Buy | $18 | $2.22 | +710.81% | 9 | Jan 16, 2025 | |
| AVXL Anavex Life Sciences | Maintains: Buy | $46 | $9.21 | +399.46% | 8 | Jan 15, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $20 | $2.95 | +577.97% | 4 | Jan 15, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $25 | $10.27 | +143.43% | 7 | Jan 15, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $9 | $1.01 | +791.09% | 2 | Jan 15, 2025 | |
| ARTL Artelo Biosciences | Maintains: Buy | $6 | $1.15 | +421.74% | 3 | Jan 14, 2025 | |
| ANIX Anixa Biosciences | Maintains: Buy | $10 | $2.41 | +314.94% | 7 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $128 → $16 | $3.98 | +302.52% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $4.41 | +466.89% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $1.03 | +870.87% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.17 | +23.25% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $0.41 | +2,114.57% | 4 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.63 | +696.05% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 | $2.60 | +1,130.77% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $3.76 | +458.51% | 9 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $8.65 | +189.02% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $1.50 | +233.33% | 4 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 | $0.95 | +1,683.84% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $3.30 | +172.73% | 8 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 | $4.01 | +673.07% | 6 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $8.41 | +173.48% | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 | $0.59 | +240.48% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $1.66 | +622.89% | 4 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $1.55 | +545.16% | 6 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 | $1.75 | +814.29% | 6 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 | $4.79 | +380.17% | 7 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 | $0.91 | +3,075.99% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $5.38 | +178.81% | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $1.13 | +1,050.44% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.11 | - | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.83 | +391.80% | 2 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 | $4.03 | +247.39% | 3 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $1.77 | +747.46% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.73 | +420.23% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $0.54 | +455.66% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $5.01 | +319.16% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.27 | +372.44% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $96 | $0.24 | +40,664.33% | 1 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.35 | - | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16,002 → $45,990 | $2.92 | +1,574,900.00% | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.72 | +16,566.67% | 1 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.13 | +4,526.06% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.18 | - | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.13 | - | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.60 | - | 1 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $40 | $1.30 | +2,976.92% | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $32 | $1.39 | +2,202.16% | 8 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $720 → $480 | $2.35 | +20,325.53% | 2 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Sell | n/a | $6.01 | - | 4 | Jun 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.65 | - | 2 | Mar 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $135 | $1.89 | +7,042.86% | 1 | Aug 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.10 | - | 2 | May 18, 2017 |
Carisma Therapeutics
Jan 17, 2025
Maintains: Buy
Price Target: $12
Current: $0.44
Upside: +2,622.94%
Omeros
Jan 16, 2025
Maintains: Buy
Price Target: $36
Current: $9.33
Upside: +285.85%
ImmunityBio
Jan 16, 2025
Maintains: Buy
Price Target: $30
Current: $2.94
Upside: +920.41%
GeoVax Labs
Jan 16, 2025
Maintains: Buy
Price Target: $18
Current: $2.22
Upside: +710.81%
Anavex Life Sciences
Jan 15, 2025
Maintains: Buy
Price Target: $46
Current: $9.21
Upside: +399.46%
OS Therapies
Jan 15, 2025
Maintains: Buy
Price Target: $20
Current: $2.95
Upside: +577.97%
UroGen Pharma
Jan 15, 2025
Maintains: Buy
Price Target: $25
Current: $10.27
Upside: +143.43%
Context Therapeutics
Jan 15, 2025
Maintains: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Artelo Biosciences
Jan 14, 2025
Maintains: Buy
Price Target: $6
Current: $1.15
Upside: +421.74%
Anixa Biosciences
Jan 14, 2025
Maintains: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
Jan 13, 2025
Maintains: Buy
Price Target: $128 → $16
Current: $3.98
Upside: +302.52%
Jan 13, 2025
Maintains: Buy
Price Target: $25
Current: $4.41
Upside: +466.89%
Jan 13, 2025
Maintains: Buy
Price Target: $10
Current: $1.03
Upside: +870.87%
Jan 13, 2025
Initiates: Buy
Price Target: $15
Current: $12.17
Upside: +23.25%
Jan 10, 2025
Maintains: Buy
Price Target: $9
Current: $0.41
Upside: +2,114.57%
Jan 8, 2025
Maintains: Buy
Price Target: $5
Current: $0.63
Upside: +696.05%
Jan 8, 2025
Maintains: Buy
Price Target: $32
Current: $2.60
Upside: +1,130.77%
Jan 8, 2025
Maintains: Buy
Price Target: $21
Current: $3.76
Upside: +458.51%
Jan 8, 2025
Maintains: Buy
Price Target: $25
Current: $8.65
Upside: +189.02%
Jan 7, 2025
Maintains: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
Jan 7, 2025
Maintains: Buy
Price Target: $17
Current: $0.95
Upside: +1,683.84%
Jan 7, 2025
Maintains: Buy
Price Target: $9
Current: $3.30
Upside: +172.73%
Jan 6, 2025
Maintains: Buy
Price Target: $31
Current: $4.01
Upside: +673.07%
Jan 6, 2025
Initiates: Buy
Price Target: $23
Current: $8.41
Upside: +173.48%
Jan 3, 2025
Maintains: Buy
Price Target: $2
Current: $0.59
Upside: +240.48%
Jan 2, 2025
Maintains: Buy
Price Target: $12
Current: $1.66
Upside: +622.89%
Dec 31, 2024
Maintains: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Dec 27, 2024
Maintains: Buy
Price Target: $16
Current: $1.75
Upside: +814.29%
Dec 19, 2024
Maintains: Buy
Price Target: $23
Current: $4.79
Upside: +380.17%
Dec 19, 2024
Maintains: Buy
Price Target: $29
Current: $0.91
Upside: +3,075.99%
Dec 18, 2024
Maintains: Buy
Price Target: $15
Current: $5.38
Upside: +178.81%
Dec 11, 2024
Maintains: Buy
Price Target: $13
Current: $1.13
Upside: +1,050.44%
Dec 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.11
Upside: -
Dec 6, 2024
Maintains: Buy
Price Target: $9
Current: $1.83
Upside: +391.80%
Nov 27, 2024
Maintains: Buy
Price Target: $14
Current: $4.03
Upside: +247.39%
Nov 14, 2024
Maintains: Buy
Price Target: $15
Current: $1.77
Upside: +747.46%
Nov 14, 2024
Maintains: Buy
Price Target: $9
Current: $1.73
Upside: +420.23%
Nov 13, 2024
Maintains: Buy
Price Target: $3
Current: $0.54
Upside: +455.66%
Nov 11, 2024
Maintains: Buy
Price Target: $21
Current: $5.01
Upside: +319.16%
Aug 13, 2024
Maintains: Buy
Price Target: $6
Current: $1.27
Upside: +372.44%
Feb 28, 2024
Initiates: Buy
Price Target: $96
Current: $0.24
Upside: +40,664.33%
Aug 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.35
Upside: -
Feb 6, 2023
Maintains: Buy
Price Target: $16,002 → $45,990
Current: $2.92
Upside: +1,574,900.00%
Jan 30, 2023
Initiates: Buy
Price Target: $120
Current: $0.72
Upside: +16,566.67%
Jan 6, 2023
Initiates: Buy
Price Target: $6
Current: $0.13
Upside: +4,526.06%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.18
Upside: -
Sep 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.13
Upside: -
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Mar 17, 2021
Downgrades: Neutral
Price Target: $40
Current: $1.30
Upside: +2,976.92%
Nov 6, 2020
Maintains: Buy
Price Target: $33 → $32
Current: $1.39
Upside: +2,202.16%
Jul 28, 2020
Downgrades: Neutral
Price Target: $720 → $480
Current: $2.35
Upside: +20,325.53%
Jun 15, 2018
Terminates: Sell
Price Target: n/a
Current: $6.01
Upside: -
Mar 6, 2018
Downgrades: Hold
Price Target: n/a
Current: $2.65
Upside: -
Aug 17, 2017
Maintains: Buy
Price Target: $120 → $135
Current: $1.89
Upside: +7,042.86%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.10
Upside: -